全文获取类型
收费全文 | 9426篇 |
免费 | 609篇 |
国内免费 | 43篇 |
专业分类
耳鼻咽喉 | 47篇 |
儿科学 | 262篇 |
妇产科学 | 157篇 |
基础医学 | 1837篇 |
口腔科学 | 250篇 |
临床医学 | 767篇 |
内科学 | 1919篇 |
皮肤病学 | 293篇 |
神经病学 | 1200篇 |
特种医学 | 309篇 |
外科学 | 816篇 |
综合类 | 43篇 |
一般理论 | 6篇 |
预防医学 | 518篇 |
眼科学 | 142篇 |
药学 | 568篇 |
中国医学 | 19篇 |
肿瘤学 | 925篇 |
出版年
2023年 | 57篇 |
2022年 | 102篇 |
2021年 | 234篇 |
2020年 | 183篇 |
2019年 | 249篇 |
2018年 | 285篇 |
2017年 | 183篇 |
2016年 | 280篇 |
2015年 | 300篇 |
2014年 | 383篇 |
2013年 | 496篇 |
2012年 | 723篇 |
2011年 | 778篇 |
2010年 | 405篇 |
2009年 | 425篇 |
2008年 | 633篇 |
2007年 | 668篇 |
2006年 | 626篇 |
2005年 | 631篇 |
2004年 | 594篇 |
2003年 | 543篇 |
2002年 | 453篇 |
2001年 | 81篇 |
2000年 | 73篇 |
1999年 | 88篇 |
1998年 | 124篇 |
1997年 | 74篇 |
1996年 | 66篇 |
1995年 | 60篇 |
1994年 | 43篇 |
1993年 | 36篇 |
1992年 | 18篇 |
1991年 | 22篇 |
1990年 | 16篇 |
1989年 | 19篇 |
1988年 | 8篇 |
1987年 | 8篇 |
1986年 | 12篇 |
1985年 | 10篇 |
1984年 | 6篇 |
1983年 | 10篇 |
1981年 | 4篇 |
1979年 | 9篇 |
1978年 | 4篇 |
1977年 | 4篇 |
1975年 | 4篇 |
1973年 | 5篇 |
1972年 | 5篇 |
1971年 | 3篇 |
1963年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
111.
Kreyenschulte Thea Bohnet-Joschko Sabine 《Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz》2022,65(9):881-890
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - Als ?Generation Y“ werden jüngere Erwachsene bezeichnet, die im ungefähren Zeitraum von... 相似文献
112.
Neuhann Florian Ginzel Sebastian Buess Michael Wolff Anna Kugler Sabine Schlanstedt Gnter Kossow Annelene Nieen Johannes Rping Stefan 《Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz》2022,65(9):853-862
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - Schon in der frühen Phase der global sehr verschieden verlaufenden COVID-19-Pandemie zeigten sich Hinweise auf den Einfluss... 相似文献
113.
Waiting times from abnormal breast screen to diagnosis in 7 Canadian provinces 总被引:5,自引:4,他引:1 下载免费PDF全文
114.
Lisa J Frigati Katalin A Wilkinson Stanzi le Roux Karryn Brown Sheena Ruzive Leah Githinji Wonita Petersen Sabine Belard Mark F Cotton Landon Myer Heather J Zar 《Journal of the International AIDS Society》2021,24(3)
IntroductionThere are limited data on Tuberculosis (TB) in adolescents with perinatally acquired HIV (APHIV). We examined the incidence and determinants of TB infection and disease in the Cape Town Adolescent Antiretroviral Cohort (CTAAC).MethodsYouth between nine and fourteen years on antiretroviral therapy (ART) for more than six months in public sector care, and age‐matched HIV‐negative adolescents, were enrolled between July 2013 through March 2015 and followed six‐monthly. Data were censored on 31 October 2018. Symptom screening, chest radiograph, viral load, CD4 count, QuantiFERON (QFT) and sputum for Xpert MTB/RIF, microscopy, culture and sensitivity were performed annually. TB infection was defined by a QFT of >0.35 IU/mL. TB diagnosis was defined as confirmed (culture or Xpert MTB/RIF positive) or unconfirmed (clinical diagnosis and started on TB treatment). Analyses examined the incidence and determinants of TB infection and disease.ResultsOverall 496 HIV+ and 103 HIV‐negative participants (median age at enrolment 12 years (interquartile range, IQR 10.6 to 13.3) were followed for a median of 3.1 years (IQR 3.0 to 3.4); 50% (298/599) were male. APHIV initiated ART at median age 4.4 years (IQR 2.1 to 7.6). At enrolment, 376/496 (76%) had HIV viral load <40 copies/mL, median CD4 count was 713 cells/mm3 and 179/559 (32%) were QFT+, with no difference by HIV status (APHIV 154/468, 33%; HIV negative 25/91, 27%; p = 0.31). The cumulative QFT+ prevalence was similar (APHIV 225/492, 46%; 95%CI 41% to 50%; HIV negative 44/98, 45%; 95% CI 35% to 55%; p = 0.88). APHIV had a higher incidence of all TB disease than HIV‐negative adolescents (2.2/100PY, 95% CI 1.6 to 3.1 vs. 0.3/100PY, 95% CI 0.04 to 2.2; IRR 7.36, 95% CI 1.01 to 53.55). The rate of bacteriologically confirmed TB in APHIV was 1.3/100 PY compared to 0.3/100PY for HIV‐negative adolescents, suggesting a fourfold increased risk of developing TB disease in APHIV despite access to ART. In addition, a positive QFT at enrolment was not predictive of TB in this population.ConclusionsHigh incidence rates of TB disease occur in APHIV despite similar QFT conversion rates to HIV‐negative adolescents. Strategies to prevent TB in this vulnerable group must be strengthened. 相似文献
115.
Marion Migueres Sabine Chapuy-Regaud Marcel Miédougé Thibaut Jamme Catherine Lougarre Isabelle Da Silva Mélanie Pucelle Laetitia Staes Marion Porcheron Chloé Diméglio Jacques Izopet 《Journal of medical virology》2023,95(1):e28200
The present study aimed to determine whether current commercial immunoassays are adequate for detecting anti-Omicron antibodies. We analyzed the anti-SARS-CoV-2 antibody response of 23 unvaccinated individuals 1–2 months after an Omicron infection. All blood samples were tested with a live virus neutralization assay using a clinical Omicron BA.1 strain and four commercial SARS-CoV-2 immunoassays. We assessed three anti-Spike immunoassays (SARS-CoV-2 IgG II Quant [Abbott S], Wantaï anti-SARS-CoV-2 antibody ELISA [Wantaï], Elecsys Anti-SARS-CoV-2 S assay [Roche]) and one anti-Nucleocapsid immunoassay (Abbott SARS-CoV-2 IgG assay [Abbott N]). Omicron neutralizing antibodies were detected in all samples with the live virus neutralization assay. The detection rate of the Abbott S, Wantai, Roche, and Abbott N immunoassays were 65.2%, 69.6%, 86.9%, and 91.3%, respectively. The sensitivities of Abbott S and Wantai immunoassays were significantly lower than that of the live virus neutralization assay (p = 0.004, p = 0.009; Fisher's exact test). Antibody concentrations obtained with anti-S immunoassays were correlated with Omicron neutralizing antibody concentrations. These data provide clinical evidence of the loss of performance of some commercial immunoassays to detect antibodies elicited by Omicron infections. It highlights the need to optimize these assays by adapting antigens to the circulating SARS-CoV-2 strains. 相似文献
116.
The association of certain human papillomavirus (HPV) types with malignancies of the anogenital tract is well established. The virus type most frequently associated with cellular transformation is HPV 16, as has been shown in epidemiological studies. Its transforming capacity has also been demonstrated in many in vitro cell transformation experiments. The most potent oncogenes of HPV 16 are the E6 and E7 proteins, but the E5 protein, whose homologue is the main oncogene of bovine papillomavirus, has recently been identified as an oncogene also for HPV. On the basis of epidemiological and clinical data from tumor material as well as from in vitro data it has been suggested, that the HPV 16 E5 protein would have a function at the early stages of cervical carcinogenesis. The E5 protein enhances growth factor-mediated signal transduction to the nucleus and consequently augments cellular proliferation. Expression of the E5 protein enables the infected cell to escape growth control provided by surrounding cells by inhibiting gap junctional intercellular communication in epithelial cells. This viral oncogene seems to interfere with the control mechanisms of cellular growth and proliferation and thus facilitate the function of the E6 and E7 proteins and further steps towards epithelial cell transformation. 相似文献
117.
118.
119.
Emmanuel Chaubourt Philippe Fossier Grard Baux Christine Leprince Maurice Israël Sabine De La Porte 《Neurobiology of disease》1999,6(6):499
Duchenne muscular dystrophy (DMD), a severe X-linked recessive disorder which results in progressive muscle degeneration, is due to a lack of dystrophin, a membrane cytoskeletal protein. An approach to treatment is to compensate for dystrophin loss with utrophin, another cytoskeletal protein with over 80% homology with dystrophin. Utrophin is expressed, at the neuromuscular junction, in normal and DMD muscles and there is evidence that it may perform the same cellular functions as dystrophin. So, the identification of molecules or drugs that could up-regulate utrophin is a very important goal for therapy. We show that in adult normal and mdx mice (an animal model of Duchenne myopathy) treated with
-arginine, the substrate of nitric oxide synthase (NOS), a pool of utrophin localized at the membrane appeared and increased, respectively. In normal and mdx myotubes in culture,
-arginine, nitric oxide (NO), or hydroxyurea increased utrophin levels and enhanced its membrane localization. This effect did not occur with
-arginine, showing the involvement of NOS in this process. The NO-induced increase in utrophin was prevented by oxadiazolo-quinoxalin-1-one, an inhibitor of a soluble guanylate cyclase implicated in NO effects. These results open the way to a potential treatment for Duchenne and Becker dystrophies. 相似文献
120.